Positions
- Postdoctoral Associate
-
Pediatrics - Nutrition
草榴社区入口
Houston, US
- Senior Scientist
-
Analysis Science
Shanghai Hansoh Biomedical R&D Inc.
Shanghai, Shanghai China
Leading the project of novel anti-tumor Antibody-Drug Conjugates (ADCs) activity measurement methods development.
Addresses
- Children's Nutrition Research Center (Lab)
-
1100 BATES
Room 8052
Houston, TX 77030
United States
- Children's Nutrition Research Center (Office)
-
1100 BATES
Room 8062
Houston, TX 77030
United States
Education
- PharmD from China Pharmaceutical University
- 06/2021 - Nanjing, Jiangsu China
- BS from China Pharmaceutical Univeristy
- 06/2015 - Nanjing, Jiangsu China
Websites
Selected Publications
- Qian P, Tian H, Wang YK, Lu W, Li Y, Ma T, Gao X, Yao W "." Biochem Pharmacol. 2020 Dec;182(114209) Pubmed PMID:
- Ma T, Lu W, Wang Y, Qian P, Tian H, Gao X, Yao W "." Eur J Pharmacol. 2022 Jan 5;914(174635) Pubmed PMID:
- Liu W, Wang H, Yu J, Liu Y, Lu W, Chai Y, Liu C, Pan C, Yao W, Gao X "." Carbohydr Polym. 2016 Oct 5;150:149-158. Pubmed PMID:
- Liu W, Liu Y, Zhu R, Yu J, Lu W, Pan C, Yao W, Gao X "." Carbohydr Polym. 2016 Aug 20;147:114-124. Pubmed PMID:
- Liu W, Hu C, Liu Y, Dai S, Lu W, Lv X, Yao W, Gao X "." Int J Biol Macromol. 2017 Jun;99:454-464. Pubmed PMID:
- Liu W, Lu W, Chai Y, Liu Y, Yao W, Gao X "." Carbohydr Polym. 2017 Nov 15;176:140-151. Pubmed PMID:
- Lu W, Tian H, Qian P, Li Y, Wang Y, Ge Y, Sai W, Gao X, Yao W "." Br J Pharmacol. 2020 Apr 15;177(15):3473-3488. Pubmed PMID:
Intellectual Property
- Design Patent #WO2021027762A1 (Approved)
- Provided in the present invention are an oral hypoglycemic polypeptide, fatty acid modified derivatives thereof, and uses of the polypeptide and the fatty acid modified derivatives thereof.
- Co Inventors: GAO Xiangdong, TIAN Hong, LU Weisheng, YAO Wenbing, SAI Wenbo
Languages
Chinese (Mandarin), Japanese
to edit your profile
